Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium
Authors:
- Reka TothRTReka Toth
- Dominique SchererDominique Scherer
- Angela RischARAngela Risch
- Aditi HazraAHAditi Hazra
- Yesilda BalavarcaYBYesilda Balavarca
- Jean-Pierre J. IssaJIJean-Pierre J. Issa
- Victor MorenoVMVictor Moreno
- Rosalind A. EelesRERosalind A. Eeles
- Shuji OginoShuji Ogino
- Xifeng WuXWXifeng Wu
- Yuanqing YeYYYuanqing Ye
Open Access
- 31 May 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 26 (6) , 816-825
Abstract
Background: Epigenetic disturbances are crucial in cancer initiation, potentially with pleiotropic effects, and may be influenced by the genetic background. Methods: In a subsets (ASSET) meta-analytic approach, we investigated associations of genetic variants related to epigenetic mechanisms with risks of breast, lung, colorectal, ovarian and prostate carcinomas using 51,724 cases and 52,001 controls. False discovery rate–corrected P values (q values < 0.05) were considered statistically significant. Results: Among 162,887 imputed or genotyped variants in 555 candidate genes, SNPs in eight genes were associated with risk of more than one cancer type. For example, variants in BABAM1 were confirmed as a susceptibility locus for squamous cell lung, overall breast, estrogen receptor (ER)–negative breast, and overall prostate, and overall serous ovarian cancer; the most significant variant was rs4808076 [OR = 1.14; 95% confidence interval (CI) = 1.10–1.19; q = 6.87 × 10−5]. DPF1 rs12611084 was inversely associated with ER-negative breast, endometrioid ovarian, and overall and aggressive prostate cancer risk (OR = 0.93; 95% CI = 0.91–0.96; q = 0.005). Variants in L3MBTL3 were associated with colorectal, overall breast, ER-negative breast, clear cell ovarian, and overall and aggressive prostate cancer risk (e.g., rs9388766: OR = 1.06; 95% CI = 1.03–1.08; q = 0.02). Variants in TET2 were significantly associated with overall breast, overall prostate, overall ovarian, and endometrioid ovarian cancer risk, with rs62331150 showing bidirectional effects. Analyses of subpathways did not reveal gene subsets that contributed disproportionately to susceptibility. Conclusions: Functional and correlative studies are now needed to elucidate the potential links between germline genotype, epigenetic function, and cancer etiology. Impact: This approach provides novel insight into possible pleiotropic effects of genes involved in epigenetic processes. Cancer Epidemiol Biomarkers Prev; 26(6); 816–25. ©2017 AACR.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- A Subset-Based Approach Improves Power and Interpretation for the Combined Analysis of Genetic Association Studies of Heterogeneous TraitsThe American Journal of Human Genetics, 2012
- Meta-analysis of new genome-wide association studies of colorectal cancer riskHuman Genetics, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Hundreds of variants clustered in genomic loci and biological pathways affect human heightNature, 2010
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Nature Genetics, 2009
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and managementMolecular Oncology, 2009